Photo taken from Vivek Subbiah/Twitter
Sep 16, 2023, 19:08
Vivek Subbiah: Super thrilled to deliver the keynote lecture on “Precision Oncology: Future is now” at the Binaytara Foundation.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, recently shared on X/Twitter:
“Welcome to Nashville.
Super thrilled to deliver the keynote lecture on Sunday, Sep 17th, at 8:15 am on “Precision Oncology: Future is now” at the Binaytara Foundation Hemesummit23! Thanks to the amazing “N’s” of the Heme world for organizing the meeting and for the invite Navneet Majhail, Nitin Jain, Naveen Pemmaraju & biNay.
Precision Medicine is tumor-agnostic for both solid and heme malignancies.
As a solid tumor doctor, it’s always exciting to collaborate & learn from our amazing hematology doctors.”
Source: Vivek Subbiah/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19